In December 2019, an outbreak emerged of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) which leads to coronavirus disease 2019 (COVID-19). The World Health …

Introduction Several vaccines against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 …

The emergence of COVID-19 has posed an unprecedented global health crisis, challenging
the healthcare systems worldwide. Amidst the rapid development of several vaccine …

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), which causes
coronavirus disease 2019 (COVID-19), has presented numerous challenges to global …

This study is an extension of current research into a novel class of synthetic antihypertensive
drugs referred to as “bisartans”, which are bis-alkylated imidazole derivatives bearing two …

Patients with an immunocompromised state are at risk of developing a long-term infection
from the coronavirus 2 that causes severe acute respiratory syndrome (SARS-CoV-2). It has …

Introduction The emergence of SARS-CoV-2 triggered a global health emergency, causing>
7 million deaths thus far. Limited early knowledge spurred swift research, treatment, and …

The rapid development and implementation of COVID-19 vaccines merit understanding its
effects on metabolic indices. This retrospective longitudinal study investigated the influence …

The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) that causes the
coronavirus disease 2019 (COVID-19) has presented numerous challenges to global health …

Despite controversy over the protective effect of the BCG (Bacille Calmette-Guérin) vaccine
in preventing pulmonary tuberculosis (TB) in adults, it has been used worldwide since 1921 …